GSI (Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg)
Generic Name: emtricitabine/rilpivirine/tenofovir
Pill with imprint GSI is Pink, Capsule-shape and has been identified as Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg. It is supplied by Gilead Sciences, Inc..
Complera is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI
Complera
- Generic Name:
- emtricitabine/rilpivirine/tenofovir
- Imprint:
- GSI
- Strength:
- emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Gilead Sciences, Inc.
- National Drug Code (NDC):
- 61958-1101
More about Complera (emtricitabine / rilpivirine / tenofovir)
- Complera Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 56 Reviews
- Drug class: antiviral combinations
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
